Best Places To Work 2023: Medium Companies
Free Market Health recognized as the number one company in the Medium (between 25 and 49 employees) category in the 2023 Best Places to Work awards.

Streamlining healthcare with a competitive referral ecosystem for providers, payers, and patients.
freemarkethealth.comCrawled Oct 15, 2026
Free Market Health recognized as the number one company in the Medium (between 25 and 49 employees) category in the 2023 Best Places to Work awards.
Part of the Inflation Reduction Act, CMS has announced the first 10 drugs to undergo price negotiations between manufacturers and CMS to determine a new “maximum fair price."
Specialty pharmacy tech provider Free Market Health snagged a $20 million Series B round, CEO Joe Cardosi tells Axios exclusively.
Free Market Health acquires Beeline Rx to streamline specialty drug prior authorization and enhance patient access and care through technology integration.
Free Market Health is No. 5 in the 2024 Best Places to Work medium category.
Mercer today launched Mercer SelectRx, an exclusive product offering that leverages Free Market Health’s cloud-based technology platform to drive competition among specialty pharmacies for high-cost specialty medications and savings for employers and their employees.
The latest from Free Market Health (FMH)
Founded in 2019 and headquartered in Pittsburgh, PA, FMH is built on deep pharmacy expertise and one clear mission: never let the process fail the patient.
Free Market Health general inquiries.
FMH is simplifying specialty pharmacy care across providers, pharmacies, payers, and pharma—so patients don’t have to chase the care they depend on.
Free Market Health's Privacy Policy
Free Market Health appoints Chris Burns as Chief Strategy and Marketing Officer and Darcey Schoenebeck as Chief People and Transformation Officer. Both executives bring experience in healthcare, pharmacy benefit management, and organizational growth. The hires strengthen Free Market Health’s leadership in scaling operations and strategy.
Abridge and Free Market Health participated in the closing session of the Bio + Health Summit, hosted by the Pittsburgh Life Sciences Alliance. The Pittsburgh-based companies discussed their recent growth trajectories during the event. The summit highlights collaboration and innovation within the local life sciences ecosystem.
Freemarket Health (FMH) expands its specialty pharmacy model with partners like Highmark, focusing on scalable solutions for a complex drug landscape. The company prioritizes efficiency and improved patient outcomes through innovation driven by industry necessity. Discussions highlight opportunities for further growth and integration in specialty pharmacy services.
Freemarket Health (FMH) partners with Highmark Inc. to streamline specialty pharmacy services for Highmark members. The collaboration addresses challenges in the specialty pharmacy ecosystem, enhancing patient access and experience. Highmark’s Sr. Vice President of Pharmacy Services, Sarah Marche, discusses the partnership’s impact alongside FMH’s CEO, Joe Cardosi.
Highmark collaborates with Free Market Health to expand its specialty pharmacy offerings. The partnership aims to improve patient access to high-cost medications and streamline care coordination for complex treatments. Highmark leverages Free Market Health’s expertise in managing specialty drug distribution and adherence programs.
Free Market Health (FMH) acquires Beeline Rx to streamline the specialty pharmacy sector. CEO Joe Cardosi discusses leveraging technology to address fragmentation in medication access. The company expands partnerships in Pittsburgh while scaling operations nationally to enhance patient access to critical treatments.
Free Market Health secures **HITRUST r2 certification** for a second year in a row, reinforcing its commitment to stringent data security and compliance standards. The certification underscores the company’s focus on safeguarding partner data against evolving cybersecurity threats. Free Market Health emphasizes rigorous controls and continuous improvements to maintain trust in its healthcare data management systems.
Free Market Health simplifies access to high-cost specialty drugs for conditions like cancer and rare diseases. The company addresses logistical and financial hurdles in medication delivery, targeting treatments priced up to $30,000 monthly. Its solutions aim to streamline distribution for patients facing complex treatment pathways.